Showing results (1611-1620 of 2,472) with videos related to
Sort By:
Pageof 248
Cancer Treatment Reviews|July 2, 2013
Adjuvant therapy for resectable pancreatic adenocarcinoma: review of the current treatment approaches and future directionsG Antoniou, P Kountourakis, K Papadimitriou, et al.Cancer Treatment Reviews|June 18, 2013
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patientsMonic Roengvoraphoj, Gregory J Tsongalis, Konstantin H Dragnev, et al.Cancer Treatment Reviews|September 10, 2013
Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancerParvin F Peddi, Rebecca A Shatsky, Sara A HurvitzCancer Treatment Reviews|November 13, 2013
Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC)Roger B CohenCancer Treatment Reviews|September 1, 1985
Tumor markers: value and limitations in the management of cancer patientsS E Bates, D L LongoCancer Treatment Reviews|October 22, 2013
Castration-resistant prostate cancer: adaptive responses in the androgen axisAlison Egan, Yan Dong, Haitao Zhang, et al.Cancer Treatment Reviews|August 6, 2013
Adherence enhancing interventions for oral anticancer agents: a systematic reviewTim Mathes, Sunya-Lee Antoine, Dawid Pieper, et al.Cancer Treatment Reviews|September 26, 2013
Immunological challenges for peptide-based immunotherapy in glioblastomaMalte Mohme, Marian C Neidert, Luca Regli, et al.Cancer Treatment Reviews|July 9, 2013
The promise and failures of epigenetic therapies for cancer treatmentPasano Bojang, Kenneth S RamosCancer Treatment Reviews|July 9, 2013
Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: a new era beginsJ Remon, T Morán, M Majem, et al.Pageof 248